Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Virology|October 24, 2007
Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigensPavlo Sakhatskyy, Shixia Wang, Chuanyou Zhang, et al.Retrovirology|August 17, 2011
Genotypic and functional properties of early infant HIV-1 envelopesMichael Kishko, Mohan Somasundaran, Frank Brewster, et al.Virology|September 1, 2020
Evaluation of the respiratory syncytial virus G-directed neutralizing antibody response in the human airway epithelial cell modelMichael Kishko, John Catalan, Kurt Swanson, et al.Vaccines|August 28, 2025
Epitope Profiling of SARS-CoV-2 Spike Antigen Provides a Novel Strategy for Developing ELISAs Specific for Different Spike Protein Variants in Bivalent Vaccine FormulationsLuciano Ettorre, Trevor Williams, Camille Houy, et al.Plos One|June 20, 2018
Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccineRachel Groppo, Joshua DiNapoli, Kwang Il Jeong, et al.Vaccine|May 31, 2016
Core bead chromatography for preparation of highly pure, infectious respiratory syncytial virus in the negative purification modeSophia T Mundle, Michael Kishko, Rachel Groppo, et al.Human Vaccines & Immunotherapeutics|November 16, 2012
Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolatesShixia Wang, Michael Kishko, Shengqin Wan, et al.Plos One|June 25, 2015
CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent MannerKwang-Il Jeong, Peter A Piepenhagen, Michael Kishko, et al.Nature Communications|April 1, 2022
Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primatesVincent Pavot, Catherine Berry, Michael Kishko, et al.Nature Communications|March 9, 2023
Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primatesVincent Pavot, Catherine Berry, Michael Kishko, et al.Pageof 2